Complete LCAT deficiency
Zuletzt aktualisiert 18. Aug 2020
Erfüllt die redaktionelle Richtlinien
- HerunterladenHerunterladen
- Teilen
- Language
- Diskussion
- Ask Patient
- Audio-Version
- Zu bevorzugten Quellen bei Google hinzufügen
Complete LCAT deficiency is a disorder that primarily affects the eyes and kidneys.
Videoauswahl für Genetische ErkrankungenVideothek
Beschreibung
Complete LCAT deficiency is a disorder that primarily affects the eyes and kidneys.
In complete LCAT deficiency, the clear front surface of the eyes (the corneas) gradually becomes cloudy. The cloudiness, which generally first appears in early childhood, consists of small grayish dots of cholesterol (opacities) distributed across the corneas. Cholesterol is a waxy, fat-like substance that is produced in the body and obtained from foods that come from animals; it aids in many functions of the body but can become harmful in excessive amounts. As complete LCAT deficiency progresses, the corneal cloudiness worsens and can lead to severely impaired vision.
People with complete LCAT deficiency often have kidney disease that begins in adolescence or early adulthood. The kidney problems get worse over time and may eventually lead to kidney failure. Individuals with this disorder also usually have a condition known as hemolytic anaemia, in which red blood cells are broken down (undergo hemolysis) prematurely, resulting in a shortage of red blood cells (anaemia). Anaemia can cause pale skin, weakness, fatigue, and more serious complications.
Other features of complete LCAT deficiency that occur in some affected individuals include enlargement of the liver (hepatomegaly), spleen (splenomegaly), or lymph nodes (lymphadenopathy) or an accumulation of fatty deposits on the artery walls (atherosclerosis).
Inheritance patterns
The source lists the following possible inheritance patterns: Autosomal recessive. More than one pattern can apply in different cases.
Related genes
Other names
Familial LCAT deficiency
Familial lecithin-cholesterol acyltransferase deficiency
FLD
LCAT deficiency
Lecithin acyltransferase deficiency
Lecithin:cholesterol acyltransferase deficiency
Norum disease
Norum's disease
Related patient information and medicines

Patient information leaflet
Laktoseintoleranz
Some people are born with a tendency to develop lactose intolerance; others get it as a result of gastroenteritis or chemotherapy. The treatment is ma... In cultures where dairy was not a major part of the diet, there was no evolutionary benefit from being able to digest lactose in adulthood, and so no reason for the lactose persistence gene to.

Patient information leaflet
Gastrointestinale Malabsorption
Gastrointestinal malabsorption syndrome means a failure to fully absorb digested foods from the gut (bowel) into your body. There are many different causes. Some dise... The causes of gastrointestinal malabsorption include: Problems with absorbing food from the gut (bowel) into your body Coeliac disease - a long-term disease that mostly affects.

Patient information leaflet
Farbenblindheit
Colour vision deficiency, also called colour blindness, is when you are unable to see certain colours. The most common form of the condition is red-green colour vision deficiency. Key points Colour vision deficiency (colour blindness) mean... There’s no cure, but most people adapt well by using special colour filters, tinted lenses, or apps that.

Patient information leaflet
X-Beine
X-Beine describes an unusual angle von the lower legs. Most commonly it is a normal shape as children's legs develop, but occasionally in children or adults it can cause problems or have an underlying cause. Occasionally - in either older children or adults - there can be an underlying problem causing th... For example: Vitamin deficiency.

Patient information leaflet
Kann ich Esomeprazol und Indapamid zusammen einnehmen?
Why this happens Indapamide is a 'water pi... Esomeprazole ist ein Protonenpumpenhemmer (PPI) das can reduce the amount of magnesium your body absorbs from food. When used together, these effects can add up, leading to a deficiency. Haftungsausschluss This information is für general educational purposes only and should not be relied upon as a substitute.

Patient information leaflet
Alpha-1-Antitrypsin-Mangel
Alpha-1-Antitrypsin-Mangel ist ein inherited genetic condition. A genetic condition is one that can be passed on from parents through genes. In alpha-1 antitrypsin deficiency the result of a genetic abnormality leads to lung and, in some people, liver damage. Lung symptoms are the most common and include shortness of breath, cough and wheezing..
Weiterführende Lektüre und Referenzen
- Complete LCAT deficiency; MedlinePlus, National Library of Medicine.
- Calabresi L, Pisciotta L, Costantin A, Frigerio I, Eberini I, Alessandrini P, Arca M, Bon GB, Boscutti G, Busnach G, Frasca G, Gesualdo L, Gigante M, Lupattelli G, Montali A, Pizzolitto S, Rabbone I, Rolleri M, Ruotolo G, Sampietro T, Sessa A, Vaudo G, Cantafora A, Veglia F, Calandra S, Bertolini S, Franceschini G. The molecular basis of lecithin:cholesterol acyltransferase deficiency syndromes: a comprehensive study of molecular and biochemical findings in 13 unrelated Italian families. Arterioscler Thromb Vasc Biol. 2005 Sep;25(9):1972-8. doi: 10.1161/01.ATV.0000175751.30616.13. Epub 2005 Jun 30.
- Jahanzad I, Amoueian S, Attaranzadeh A. Familial lecithin-cholesterol acyltransferase deficiency. Arch Iran Med. 2009 Mar;12(2):179-81.
- Roshan B, Ganda OP, Desilva R, Ganim RB, Ward E, Haessler SD, Polisecki EY, Asztalos BF, Schaefer EJ. Homozygous lecithin:cholesterol acyltransferase (LCAT) deficiency due to a new loss of function mutation and review of the literature. J Clin Lipidol. 2011 Nov-Dec;5(6):493-9. doi: 10.1016/j.jacl.2011.07.002. Epub 2011 Aug 23.
- Savel J, Lafitte M, Pucheu Y, Pradeau V, Tabarin A, Couffinhal T. Very low levels of HDL cholesterol and atherosclerosis, a variable relationship--a review of LCAT deficiency. Vasc Health Risk Manag. 2012;8:357-61. doi: 10.2147/VHRM.S29985. Epub 2012 Jun 5.
- Shoji K, Morita H, Ishigaki Y, Rivard CJ, Takayasu M, Nakayama K, Nakayama T, Inoue Y, Ayaki M, Yoshimura A. Lecithin-cholesterol acyltransferase (LCAT) deficiency without mutations in the coding sequence: a case report and literature review. Clin Nephrol. 2011 Oct;76(4):323-8. doi: 10.5414/cn106484.
Artikelverlauf
Artikel auch verfügbar in Englisch, Deutsch, Spanisch, Französisch, Italienisch, Portugiesisch, Hindi, Hebräisch, Arabisch, und Schwedisch.
18. Aug 2020 | Neueste Version
1 Aug 2013 | Ursprünglich veröffentlicht
Teilen Sie Ihre Gedanken oder Erfahrungen mit anderen in unserem Patientengemeinschaften.
Abonnieren Sie den Patienten-Newsletter
Ihre wöchentliche Dosis klarer, vertrauenswürdiger Gesundheitsberatung - geschrieben, um Ihnen zu helfen, sich informiert, selbstbewusst und in Kontrolle zu fühlen.
Durch das Abonnieren akzeptieren Sie unsere Datenschutzrichtlinie. Sie können sich jederzeit abmelden. Wir verkaufen Ihre Daten niemals.

